Novogen Limited (KZIA) vs LENZ Therapeutics, Inc. (LENZ)

Novogen Limited and LENZ Therapeutics, Inc. are both Biotechnology companies. Novogen Limited and LENZ Therapeutics, Inc. are of similar size ($117.4M and $111.8M). Novogen Limited has the higher net margin (0.00% vs −586.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Novogen Limited leads on 8 and LENZ Therapeutics, Inc. on 4.

Valuation

Metric KZIA LENZ Biotechnology median
P/E n/m n/m 7.88
P/S n/m 5.73 11.47
P/B n/m 0.56 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 1.46 0.69 0.74
EV/Sales n/m (4.36) 10.73
Earnings yield (2.27%) (104.34%) (28.84%)
Free cash flow yield 0.00% (93.03%) (23.03%)

Profitability

Metric KZIA LENZ Biotechnology median
Gross margin 0.00% 93.69% 65.16%
Operating margin — (631.70%) 0.00%
Net margin 0.00% (586.74%) 0.00%
Free cash flow margin 0.00% (532.80%) 0.00%
Return on equity 0.00% (59.21%) (57.72%)
Return on assets 0.00% (55.52%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric KZIA LENZ Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 63.24% (21.79%) —
Revenue growth, 5-year CAGR 11.56% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KZIA LENZ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.87 13.55 4.73
Net debt to EBITDA 0.30 3.22 0.96

Dividend

Metric KZIA LENZ Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric KZIA LENZ Biotechnology median
Market cap 111.79m 117.38m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack